These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29900157)

  • 1. Agreement between the Turkey Guidelines and the Fracture Risk Assessment Tool®-based Intervention Threshold.
    Imerci A; Aydogan NH; Tosun K
    J Bone Metab; 2018 May; 25(2):79-86. PubMed ID: 29900157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia.
    Imerci A; Yalın Kılınç C; Aydogan NH; Karalezli MN; Savran A
    J Clin Densitom; 2018; 21(4):464-471. PubMed ID: 28781230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.
    Tuzun S; Eskiyurt N; Akarirmak U; Saridogan M; Johansson H; McCloskey E; Kanis JA;
    Arch Osteoporos; 2012; 7():229-35. PubMed ID: 23060308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey.
    Olmez Sarikaya N; Kapar Yavasi S; Tan G; Satiroglu S; Yildiz AH; Oz B; Yoleri O; Memis A
    Clin Rheumatol; 2014 Dec; 33(12):1785-9. PubMed ID: 24474067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
    Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
    Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.
    Ensrud KE; Taylor BC; Peters KW; Gourlay ML; Donaldson MG; Leslie WD; Blackwell TL; Fink HA; Orwoll ES; Schousboe J;
    BMJ; 2014 Jul; 349():g4120. PubMed ID: 24994809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRAX-based osteoporosis treatment guidelines for resource-poor settings in India.
    Nagendra L; Bhavani N; Menon VU; Pavithran PV; Menon AS; Abraham N; Nair V; Kumar H
    Arch Osteoporos; 2021 Apr; 16(1):69. PubMed ID: 33852082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
    Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement of Mexican FRAX with and without the value of bone mineral density in assessing the risk of fracture in daily clinical practice.
    Horta-Baas G; Pérez Bolde-Hernández A; Pérez-Pérez A; Vergara-Sánchez I; Romero-Figueroa MDS
    Med Clin (Barc); 2017 May; 148(9):387-393. PubMed ID: 28118961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
    Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
    Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
    Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
    Dimai HP; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Fahrleitner-Pammer A; Pietschmann P; Muschitz C; McCloskey EV; Kanis JA
    Arch Osteoporos; 2022 Nov; 17(1):141. PubMed ID: 36357621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients.
    Hamdy RC; Kiebzak GM
    J Clin Densitom; 2009; 12(2):158-61. PubMed ID: 19201635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of FRAX in Saudi Arabia.
    Al-Daghri NM; Sabico S; Al-Saleh Y; Sulimani R; Aljohani NJ; Sheshah E; Alodhayani A; Harvey NC; Liu E; Lorentzon M; McCloskey EV; Vandenput L; Johansson H; Kanis JA
    Arch Osteoporos; 2021 Nov; 16(1):166. PubMed ID: 34739604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of age-dependent FRAX-based intervention thresholds for Singapore.
    Kanis JA; Chandran M; Chionh SB; Ganeson G; Harvey NC; Koh WP; Kwok T; Lau TC; Liu E; Lorentzon M; McCloskey EV; Tan KB; Vandenput L; Johansson H
    Arch Osteoporos; 2020 Jul; 15(1):104. PubMed ID: 32700118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.